Precision NanoSystems (PNI) is a global leader in technologies and solutions in genetic medicine, working with over 250 industry and academic partners. The company offers proprietary technology platforms and expertise in self-amplifying mRNA vectors, lipid-based drug delivery systems, and nanomedicine manufacturing. PNI provides solutions for the development of vaccines, gene therapies, and cell therapies across infectious diseases, oncology, and rare diseases. With new government support, PNI will advance a cost-effective Made-in-Canada COVID-19 mRNA vaccine candidate through pre-clinical studies and clinical trials. The company also intends to build technologies and capabilities to enable rapid response against future pandemics.

Total raised

$18M

Funding rounds

1

Latest round

Equity

Latest activity

Oct 2020